The global Cefprozil market size was valued at US$ 144 million in 2024 and is forecast to a readjusted size of USD 179 million by 2031 with a CAGR of 3.2% during review period.
Cefprozil is a semi-synthetic broad-spectrum cephalosporin antibiotic, and it is a second-generation cephalosporin type antibiotic. It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections. It comes as a tablet and as a liquid suspension.
Global Cefprozil key players include Orchid, Taj Pharma, Dhanuka, Qilu Antibiotics, Dongying Pharma, etc. Global top five manufacturers hold a share over 45%.
India is the largest market, with a share about 50%, followed by China, and Europe, both have a share about 40 percent.
In terms of product, Anhydrous is the largest segment, with a share over 60%. And in terms of application, the largest application is Uncomplicated Skin, followed by Pharyngitis or tonsillitis, Secondary Bacterial Infection, Acute Sinusitis, etc.
This report is a detailed and comprehensive analysis for global Cefprozil market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cefprozil market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (USD/Kg), 2020-2031
Global Cefprozil market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (USD/Kg), 2020-2031
Global Cefprozil market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (USD/Kg), 2020-2031
Global Cefprozil market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (USD/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cefprozil
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cefprozil market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Orchid, Taj Pharma, Dhanuka, Lupin, Alkem, Corden Pharma, Aurobindo, Covalent, TEVA GROUP, Hetero Drugs, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Cefprozil market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Anhydrous
Monohydrate
麻豆原创 segment by Application
Pharyngitis or tonsillitis
Otitis Media
Acute Sinusitis
Secondary Bacterial Infection
Uncomplicated Skin
Other
Major players covered
Orchid
Taj Pharma
Dhanuka
Lupin
Alkem
Corden Pharma
Aurobindo
Covalent
TEVA GROUP
Hetero Drugs
Qilu Antibiotics
Dongying Pharma
Union Chempharma
Huafangpharm
Topfond
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cefprozil product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cefprozil, with price, sales quantity, revenue, and global market share of Cefprozil from 2020 to 2025.
Chapter 3, the Cefprozil competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cefprozil breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Cefprozil market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cefprozil.
Chapter 14 and 15, to describe Cefprozil sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Cefprozil Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Anhydrous
1.3.3 Monohydrate
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Cefprozil Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Pharyngitis or tonsillitis
1.4.3 Otitis Media
1.4.4 Acute Sinusitis
1.4.5 Secondary Bacterial Infection
1.4.6 Uncomplicated Skin
1.4.7 Other
1.5 Global Cefprozil 麻豆原创 Size & Forecast
1.5.1 Global Cefprozil Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Cefprozil Sales Quantity (2020-2031)
1.5.3 Global Cefprozil Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Orchid
2.1.1 Orchid Details
2.1.2 Orchid Major Business
2.1.3 Orchid Cefprozil Product and Services
2.1.4 Orchid Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Orchid Recent Developments/Updates
2.2 Taj Pharma
2.2.1 Taj Pharma Details
2.2.2 Taj Pharma Major Business
2.2.3 Taj Pharma Cefprozil Product and Services
2.2.4 Taj Pharma Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Taj Pharma Recent Developments/Updates
2.3 Dhanuka
2.3.1 Dhanuka Details
2.3.2 Dhanuka Major Business
2.3.3 Dhanuka Cefprozil Product and Services
2.3.4 Dhanuka Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Dhanuka Recent Developments/Updates
2.4 Lupin
2.4.1 Lupin Details
2.4.2 Lupin Major Business
2.4.3 Lupin Cefprozil Product and Services
2.4.4 Lupin Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Lupin Recent Developments/Updates
2.5 Alkem
2.5.1 Alkem Details
2.5.2 Alkem Major Business
2.5.3 Alkem Cefprozil Product and Services
2.5.4 Alkem Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Alkem Recent Developments/Updates
2.6 Corden Pharma
2.6.1 Corden Pharma Details
2.6.2 Corden Pharma Major Business
2.6.3 Corden Pharma Cefprozil Product and Services
2.6.4 Corden Pharma Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Corden Pharma Recent Developments/Updates
2.7 Aurobindo
2.7.1 Aurobindo Details
2.7.2 Aurobindo Major Business
2.7.3 Aurobindo Cefprozil Product and Services
2.7.4 Aurobindo Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Aurobindo Recent Developments/Updates
2.8 Covalent
2.8.1 Covalent Details
2.8.2 Covalent Major Business
2.8.3 Covalent Cefprozil Product and Services
2.8.4 Covalent Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Covalent Recent Developments/Updates
2.9 TEVA GROUP
2.9.1 TEVA GROUP Details
2.9.2 TEVA GROUP Major Business
2.9.3 TEVA GROUP Cefprozil Product and Services
2.9.4 TEVA GROUP Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 TEVA GROUP Recent Developments/Updates
2.10 Hetero Drugs
2.10.1 Hetero Drugs Details
2.10.2 Hetero Drugs Major Business
2.10.3 Hetero Drugs Cefprozil Product and Services
2.10.4 Hetero Drugs Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Hetero Drugs Recent Developments/Updates
2.11 Qilu Antibiotics
2.11.1 Qilu Antibiotics Details
2.11.2 Qilu Antibiotics Major Business
2.11.3 Qilu Antibiotics Cefprozil Product and Services
2.11.4 Qilu Antibiotics Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Qilu Antibiotics Recent Developments/Updates
2.12 Dongying Pharma
2.12.1 Dongying Pharma Details
2.12.2 Dongying Pharma Major Business
2.12.3 Dongying Pharma Cefprozil Product and Services
2.12.4 Dongying Pharma Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Dongying Pharma Recent Developments/Updates
2.13 Union Chempharma
2.13.1 Union Chempharma Details
2.13.2 Union Chempharma Major Business
2.13.3 Union Chempharma Cefprozil Product and Services
2.13.4 Union Chempharma Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Union Chempharma Recent Developments/Updates
2.14 Huafangpharm
2.14.1 Huafangpharm Details
2.14.2 Huafangpharm Major Business
2.14.3 Huafangpharm Cefprozil Product and Services
2.14.4 Huafangpharm Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Huafangpharm Recent Developments/Updates
2.15 Topfond
2.15.1 Topfond Details
2.15.2 Topfond Major Business
2.15.3 Topfond Cefprozil Product and Services
2.15.4 Topfond Cefprozil Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 Topfond Recent Developments/Updates
3 Competitive Environment: Cefprozil by Manufacturer
3.1 Global Cefprozil Sales Quantity by Manufacturer (2020-2025)
3.2 Global Cefprozil Revenue by Manufacturer (2020-2025)
3.3 Global Cefprozil Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Cefprozil by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Cefprozil Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Cefprozil Manufacturer 麻豆原创 Share in 2024
3.5 Cefprozil 麻豆原创: Overall Company Footprint Analysis
3.5.1 Cefprozil 麻豆原创: Region Footprint
3.5.2 Cefprozil 麻豆原创: Company Product Type Footprint
3.5.3 Cefprozil 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Cefprozil 麻豆原创 Size by Region
4.1.1 Global Cefprozil Sales Quantity by Region (2020-2031)
4.1.2 Global Cefprozil Consumption Value by Region (2020-2031)
4.1.3 Global Cefprozil Average Price by Region (2020-2031)
4.2 North America Cefprozil Consumption Value (2020-2031)
4.3 Europe Cefprozil Consumption Value (2020-2031)
4.4 Asia-Pacific Cefprozil Consumption Value (2020-2031)
4.5 South America Cefprozil Consumption Value (2020-2031)
4.6 Middle East & Africa Cefprozil Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Cefprozil Sales Quantity by Type (2020-2031)
5.2 Global Cefprozil Consumption Value by Type (2020-2031)
5.3 Global Cefprozil Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Cefprozil Sales Quantity by Application (2020-2031)
6.2 Global Cefprozil Consumption Value by Application (2020-2031)
6.3 Global Cefprozil Average Price by Application (2020-2031)
7 North America
7.1 North America Cefprozil Sales Quantity by Type (2020-2031)
7.2 North America Cefprozil Sales Quantity by Application (2020-2031)
7.3 North America Cefprozil 麻豆原创 Size by Country
7.3.1 North America Cefprozil Sales Quantity by Country (2020-2031)
7.3.2 North America Cefprozil Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Cefprozil Sales Quantity by Type (2020-2031)
8.2 Europe Cefprozil Sales Quantity by Application (2020-2031)
8.3 Europe Cefprozil 麻豆原创 Size by Country
8.3.1 Europe Cefprozil Sales Quantity by Country (2020-2031)
8.3.2 Europe Cefprozil Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Cefprozil Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Cefprozil Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Cefprozil 麻豆原创 Size by Region
9.3.1 Asia-Pacific Cefprozil Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Cefprozil Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Cefprozil Sales Quantity by Type (2020-2031)
10.2 South America Cefprozil Sales Quantity by Application (2020-2031)
10.3 South America Cefprozil 麻豆原创 Size by Country
10.3.1 South America Cefprozil Sales Quantity by Country (2020-2031)
10.3.2 South America Cefprozil Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Cefprozil Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Cefprozil Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Cefprozil 麻豆原创 Size by Country
11.3.1 Middle East & Africa Cefprozil Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Cefprozil Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Cefprozil 麻豆原创 Drivers
12.2 Cefprozil 麻豆原创 Restraints
12.3 Cefprozil Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Cefprozil and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cefprozil
13.3 Cefprozil Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cefprozil Typical Distributors
14.3 Cefprozil Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Orchid
Taj Pharma
Dhanuka
Lupin
Alkem
Corden Pharma
Aurobindo
Covalent
TEVA GROUP
Hetero Drugs
Qilu Antibiotics
Dongying Pharma
Union Chempharma
Huafangpharm
Topfond
听
听
*If Applicable.
